These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18393254)

  • 1. [Establishing a single-tube fluorescent bidirectional PCR method to detect the 609C/T polymorphism of NQO1 gene].
    Ye R; Lai Y; Pan JC
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):230-2. PubMed ID: 18393254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of (NAD(P)H:Quinone oxidoreductase-1, EC 1.6.99.2) 609C-->T and 465C-->T polymorphisms in formalin-fixed, paraffin-embedded human tumour tissue using PCR-RFLP.
    Phillips RM; Basu S; Brown JE; Flannigan GM; Loadman PM; Martin SW; Naylor B; Puri R; Shah T
    Int J Oncol; 2004 Apr; 24(4):1005-10. PubMed ID: 15010841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in prostate cancer.
    Ergen HA; Gormus U; Narter F; Zeybek U; Bulgurcuoglu S; Isbir T
    Anticancer Res; 2007; 27(6B):4107-10. PubMed ID: 18225579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Establishment and preliminary application of polymerase chain reaction with confronting two-pair primers for the single nucleotide polymorphisms of metabolic enzymes].
    Fu J; Yang YR; Ni XJ; Pan XD; Zheng JJ; Zheng SL; Lin RY; Cai M; Chen BC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jan; 30(1):63-7. PubMed ID: 19565852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Null association of NQO1 609C>T and NQO2 -3423G>A polymorphisms with susceptibility and prognosis of Esophageal cancer in north Indian population and meta-analysis.
    Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
    Cancer Epidemiol; 2012 Dec; 36(6):e373-9. PubMed ID: 22770696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: A potential biomarker of early damage in the pancreas.
    Lyn-Cook BD; Yan-Sanders Y; Moore S; Taylor S; Word B; Hammons GJ
    Cell Biol Toxicol; 2006 Mar; 22(2):73-80. PubMed ID: 16532285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association between NAD(P)H: quinone oxidoreductase and apolipoprotein E gene polymorphisms in Alzheimer's disease].
    Ma QL; Yang JF; Shao M; Dong XM; Chen B
    Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2124-7. PubMed ID: 14720419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia.
    Sirma S; Agaoglu L; Yildiz I; Cayli D; Horgusluoglu E; Anak S; Yuksel L; Unuvar A; Celkan T; Apak H; Karakas Z; Devecioglu O; Ozbek U
    Pediatr Blood Cancer; 2004 Oct; 43(5):568-70. PubMed ID: 15382274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of NQO1 609C>T and NQO2-3423G>A polymorphisms in susceptibility to gastric cancer in Kashmir valley.
    Malik MA; Zargar SA; Mittal B
    DNA Cell Biol; 2011 May; 30(5):297-303. PubMed ID: 21294640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C.
    Fleming RA; Drees J; Loggie BW; Russell GB; Geisinger KR; Morris RT; Sachs D; McQuellon RP
    Pharmacogenetics; 2002 Jan; 12(1):31-7. PubMed ID: 11773862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlative polymorphism of NAD(P)H: quinone oxidoreductase (NQO1) with telomere shortening in colorectal cancer.
    Takagi S; Kinouchi Y; Hiwatashi N; Hirai M; Suzuki S; Takahashi S; Negoro K; Obana N; Shimosegawa T
    Anticancer Res; 2002; 22(5):2749-52. PubMed ID: 12529991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of NQO1 levels and its genetic polymorphism with susceptibility to methamphetamine dependence.
    Liu H; Zhang W; Deng XD; Ma Y; Liu Y
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1789. PubMed ID: 34467676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quadruplex tetra-primer ARMS-PCR method for the simultaneous detection of TP53 Arg72Pro, IVS3 16bp Del/Ins and IVS6+62A>G, and NQO1 C609T polymorphisms.
    Lajin B; Alachkar A; Alhaj Sakur A
    Gene; 2012 Aug; 504(2):268-73. PubMed ID: 22633876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An association between a NQO1 genetic polymorphism and risk of lung cancer.
    Saldivar SJ; Wang Y; Zhao H; Shao L; Lin J; Spitz MR; Wu X
    Mutat Res; 2005 Apr; 582(1-2):71-8. PubMed ID: 15781212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on genetic polymorphism of NQO1 and susceptibility to benzene poisoning].
    Chen Y; Ji Z; Xu J; Wu C; Li G
    Wei Sheng Yan Jiu; 2004 Nov; 33(6):657-9. PubMed ID: 15727169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer].
    Zhang JH; Li Y; Wang R; Sarbia M; Guo W; Wen DG; Wei LZ; Chen ZF; Kuang G; Zhang LW; He M; Wu ML; Wang SJ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):544-6. PubMed ID: 14669229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study on the relationship between polymorphism of human NAD(P)H: quinone oxidoreductase and Parkinson's disease in Chinese].
    Jiang XH; Yang H; Yang JF; Wang HT; Xu QY; Chen B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):120-3. PubMed ID: 15079792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association analyses between polymorphisms of the phase II detoxification enzymes (GSTM1, NQO1, NQO2) and alcohol withdrawal symptoms.
    Okubo T; Harada S; Higuchi S; Matsushita S
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):68S-71S. PubMed ID: 12960511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of alternative splicing for expression of a variant NAD(P)H:quinone oxidoreductase-1 with a single nucleotide polymorphism at 465C>T.
    Pan SS; Han Y; Farabaugh P; Xia H
    Pharmacogenetics; 2002 Aug; 12(6):479-88. PubMed ID: 12172217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.